SENP1-mediated IRF1 deSUMOylation drives Caspase-1 and GSDMD transcription to potentiate NLRP3 inflammasome responses and atherosclerosis

The human body is a vast network of blood vessels, lined with a delicate layer of cells that act as a barrier between the flowing blood and the vessel walls. When this lining becomes irritated or damaged, it can trigger a chain reaction of inflammation that leads to atherosclerosis, a condition where fatty plaques build up inside the arteries. This buildup narrows the vessels and can eventually cause heart attacks or strokes. For decades, scientists have known that a specific type of immune response, involving tiny molecular machines called inflammasomes, plays a central role in this process. These machines act like cellular alarms; when they are triggered by stress or harmful substances, they sound the alarm by releasing powerful inflammatory signals. However, a critical question has remained unanswered: how do the cells lining the blood vessels decide to turn these alarms on in the first place? Specifically, what controls the production of the very components needed to build these alarm systems?

A team of researchers at Zhejiang University and Yale University has now uncovered a hidden switch that controls this process. They discovered that a specific enzyme, which acts like a molecular editor, can remove a chemical tag from a master regulator protein, effectively unlocking its ability to turn on the genes responsible for the inflammatory alarm. This finding reveals a precise mechanism by which the body's own defense systems can be hijacked to drive the chronic inflammation seen in heart disease. The researchers traced the path from a common dietary trigger to the activation of these inflammatory genes, showing that the removal of a single chemical tag is the key step that allows the process to proceed.

The story begins with a common dietary component: oxidized low-density lipoprotein, often referred to as Ox-LDL. This substance accumulates in the blood when fats are processed in a way that makes them harmful to the body. When the cells lining the arteries are exposed to Ox-LDL, they react by increasing the production of an enzyme called SENP1. This enzyme acts as a specialized cutter, designed to snip off a small protein tag known as SUMO. In the context of this research, the scientists found that SENP1 targets a specific protein called IRF1. Under normal conditions, IRF1 carries the SUMO tag, which keeps it in a quiet, inactive state, unable to perform its job. When SENP1 levels rise due to the presence of Ox-LDL, the enzyme strips away the SUMO tag from IRF1.

Once the SUMO tag is removed, a dramatic change occurs. The now-unmasked IRF1 protein undergoes a second chemical modification, gaining a different tag called an acetyl group at a specific spot. This acetylation acts like a green light, allowing IRF1 to travel to the cell's DNA and bind tightly to the instructions for two critical proteins: Caspase-1 and GSDMD. These two proteins are the essential building blocks of the inflammasome alarm. Caspase-1 is the enzyme that cuts and activates the inflammatory signal, while GSDMD is the protein that punches holes in the cell membrane to release that signal into the surrounding tissue. By binding to the DNA, the modified IRF1 acts as a powerful switch, turning on the production of Caspase-1 and GSDMD in large quantities.

The researchers confirmed this chain of events through a series of careful experiments. They looked at human arteries from patients with severe heart disease and found that the levels of SENP1 were significantly higher in the damaged areas compared to healthy tissue. In these same areas, the levels of Caspase-1 and GSDMD were also elevated. To prove that SENP1 was the cause and not just a bystander, the team created mice that lacked the SENP1 enzyme specifically in their blood vessel lining. When these mice were fed a high-fat diet to induce heart disease, they developed far fewer plaques and showed much less inflammation than normal mice. Crucially, the cells in their blood vessels did not produce the high levels of Caspase-1 and GSDMD seen in the control animals, demonstrating that without SENP1, the inflammatory alarm could not be fully armed.

To understand the exact molecular mechanics, the scientists manipulated the IRF1 protein in the lab. They created a version of IRF1 that could not be tagged with SUMO, mimicking the state created by SENP1. When they introduced this untagged version into cells, the cells immediately began producing high levels of Caspase-1 and GSDMD, even without the presence of the harmful dietary trigger. However, when they made a second change to this protein, preventing the acetylation step, the effect vanished. The protein could no longer bind to the DNA, and the production of the inflammatory proteins stopped. This proved that the removal of the SUMO tag was not enough on its own; it had to be followed by the addition of the acetyl group to fully activate the process.

The study also explored what happens when this pathway is forced to stay active. The researchers used a virus to deliver the untagged, hyper-active version of IRF1 into the blood vessels of mice. These mice developed severe atherosclerosis much faster than those with normal IRF1. Their arteries were filled with larger plaques and showed signs of intense inflammation, with a heavy accumulation of immune cells. This confirmed that the pathway is not just a passive response but an active driver of the disease. The researchers also noted that this mechanism does not appear to affect the body's overall cholesterol levels or weight, suggesting that the problem lies specifically in how the blood vessel cells interpret and respond to inflammatory signals, rather than in the metabolism of fats themselves.

This discovery offers a new perspective on how inflammation is regulated at the genetic level. It shows that the cell uses a two-step chemical process to control the production of its own defense mechanisms. First, a specific enzyme removes an inhibitory tag, and second, an activating tag is added to the same protein. This sequence ensures that the inflammatory response is only fully turned on when the cell is under genuine stress. The findings suggest that targeting this specific interaction between SENP1 and IRF1 could provide a way to calm the inflammation in blood vessels without shutting down the entire immune system. Unlike current treatments that block the inflammatory signals after they have been released, this approach would stop the production of the alarm components before they are even made.

The researchers emphasize that while their work points to a promising new target, the path to a treatment is long. They have shown that this mechanism exists in mice and correlates with human disease, but more work is needed to see if blocking it in humans would be safe and effective. They also noted that their study focused specifically on the cells lining the blood vessels, and it remains to be seen if this same mechanism operates in other types of cells involved in heart disease. Nevertheless, the identification of this precise molecular switch provides a clear roadmap for understanding how a common dietary stressor can lead to chronic inflammation and offers a concrete starting point for developing new therapies to protect the heart.